Figure 5.

Changes in urinary CTX-II levels after treatment of osteoarthritis patients with placebo or risedronate. Ris, risedronate.

Spector et al. Arthritis Research & Therapy 2005 7:R625-R633   doi:10.1186/ar1716
Download authors' original image